UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000043188 |
|---|---|
| Receipt number | R000049292 |
| Scientific Title | Non-randomized prospective study to verify the usefulness and safety of olanzapine as an antiemetic in transcatheter arterial chemoembolization for hepatocellular carcinoma. |
| Date of disclosure of the study information | 2021/04/01 |
| Last modified on | 2025/08/03 14:11:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/01/30 18:33:37 | ||
| 2 | Update | 2021/01/30 18:34:57 | Anticipated trial start date |
|
| 3 | Update | 2021/02/27 12:56:59 | Target sample size |
|
| 4 | Update | 2022/01/08 20:54:40 | Date of IRB |
|
| 5 | Update | 2022/02/01 18:16:27 | Recruitment status |
|
| 6 | Update | 2022/08/13 18:46:04 | Results Delayed Results Delay Reason Results Delay Reason |
|
| 7 | Update | 2023/02/01 15:29:27 | Date of closure to data entry |
|
| 8 | Update | 2023/08/06 11:40:18 | Number of participants that the trial has enrolled |
|
| 9 | Update | 2024/02/12 13:10:51 | Results Results Results date posted |
|
| 10 | Update | 2024/08/05 19:26:11 | Results Delay Reason |
|
| 11 | Update | 2025/02/02 11:39:59 | Results Results |
|
| 12 | Update | 2025/08/03 14:02:15 | Recruitment status |
|
| 13 | Update | 2025/08/03 14:11:23 | URL releasing protocol Publication of results URL related to results and publications Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
